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Crystal structure of an aminoglycoside 6′-N-acetyltransferase:
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and Albert M Berghuis
Background: The predominant mechanism of antibiotic resistance employed by
pathogenic bacteria against the clinically used aminoglycosides is chemical
modification of the drug. The detoxification reactions are catalyzed by enzymes
that promote either the phosphorylation, adenylation or acetylation of
aminoglycosides. Structural studies of these aminoglycoside-modifying enzymes
may assist in the development of therapeutic agents that could circumvent
antibiotic resistance. In addition, such studies may shed light on the development
of antibiotic resistance and the evolution of different enzyme classes.
Results: The crystal structure of the aminoglycoside-modifying enzyme
aminoglycoside 6′-N-acetyltransferase type Ii (AAC(6′)-Ii) in complex with the
cofactor acetyl coenzyme A has been determined at 2.7 Å resolution. The
structure establishes that this acetyltransferase belongs to the GCN5-related
N-acetyltransferase superfamily, which includes such enzymes as the histone
acetyltransferases GCN5 and Hat1.
Conclusions: Comparison of the AAC(6′)-Ii structure with the crystal structures
of two other members of this superfamily, Serratia marcescens aminoglycoside
3-N-acetyltransferase and yeast histone acetyltransferase Hat1, reveals that of
the 84 residues that are structurally similar, only three are conserved and none
can be implicated as catalytic residues. Despite the negligible sequence
identity, functional studies show that AAC(6′)-Ii possesses protein acetylation
activity. Thus, AAC(6′)-Ii is both a structural and functional homolog of the
GCN5-related histone acetyltransferases.
Introduction
The increasing ability of bacteria to resist the effects of
antibiotics, thus compromising the treatment of microbial
infections, has provoked serious concern within the
healthcare system [1–3]. The situation has, in fact, degen-
erated to such levels that bacterial strains have emerged
that are immune to most, if not all, clinically useful
antibacterial agents. Examples of these resistant microbes
include vancomycin-resistant enterococci (VRE) and
methicillin-resistant Staphylococcus aureus (MRSA), which
have created havoc in hospitals [3–5]. The continuous
evolution of antibiotic resistance by bacteria has motivated
extensive research in this area, and much is currently
known about the diverse mechanisms employed by bacte-
ria for circumventing the deleterious effects of antimicro-
bial agents [6]. For example, the mechanism by which
Gram-positive bacteria, like enterococci and staphylo-
cocci, circumvent the effects of aminoglycoside anti-
biotics, such as gentamicin and amikacin, is through
chemical modification of the drug [7,8]. These clinically
used drugs normally act by binding to the 16S ribosomal
RNA [9,10], thus interfering with the translation of pro-
teins and ultimately culminating in cell death. Chemical
modification of the antibiotic, however, results in an
altered affinity of the drug for its target, hence producing
the antibiotic-resistant phenotype.
The chemical transformation of aminoglycoside antibi-
otics is catalyzed by a group of enzymes that are organized
into three classes: those enzymes that N-acetylate, those
that O-phosphorylate and those that O-adenylate the sub-
strate [7,8]. This division into three classes does not imply
that enzymes within a class are necessarily homologous at
the amino acid level. For example, within the aminoglyco-
side acetyltransferase class (AAC) four different subclasses
can be identified on the basis of the regiospecificity of acyl
transfer, and within these subclasses several divisions exist
based on amino acid sequence homology [7].
The three-dimensional structures of three aminoglyco-
side-modifying enzymes have been determined, one
adenyltransferase (ANT(4′)-Ia) [11,12], one phospho-
transferase (APH(3′)-IIIa) [13], and recently an acetyl-
transferase (AAC(3)-Ia) [14]. These structures have not
only provided insight into the mechanism of antibiotic
resistance at the atomic level, but, in addition, they have
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established unexpected evolutionary links between bac-
terial aminoglycoside-modifying enzymes and several
critical enzyme families present in eukaryotes. The
crystal structure of the ANT(4′)-Ia enzyme shows homol-
ogy to a eukaryotic DNA polymerase β, thus indicating
that these enzymes may have evolved from a common
ancestor [15]. The APH(3′)-IIIa structure reveals a strik-
ing, but unanticipated, similarity to protein kinases,
thereby linking these two classes of enzymes [13].
Finally, the fold of AAC(3)-Ia is also observed in the yeast
histone acetyltransferase Hat1 structure (yHat1) [16,17]
and the Candida albicans and Saccharomyces cerevisiae
N-myristoyltransferases (Nmt) [18–20].
The similarity in structure observed for AAC(3)-Ia and the
yHat1 protein is of specific interest not only because it
links these two enzymes, but in addition it provides
insight into the fold of a large N-acetyltransferase super-
family, the GCN5-related N-acetyltransferase (GNAT)
superfamily [21]. This superfamily spans all kingdoms of
life and comprises more than a dozen protein families.
These include, for example, the GCN5-related histone
acetyltransferases, the yeast Mak3 and Spt10 proteins, and
the pineal serotonin N-acetyltransferase.
We report here the structure of a second AAC enzyme,
aminoglycoside 6′-N-acetyltransferase type Ii (AAC(6′)-Ii)
in complex with acetyl coenzyme A (AcCoA). This 20.7
kDa antibiotic resistance protein was first identified in
Enterococcus faecium by Courvalin and coworkers [22], and
the gene for the protein was subsequently cloned and
overexpressed in Escherichia coli [23]. This work opened
the door for detailed studies on the mechanism of action
of AAC(6′)-Ii, and to date the kinetic parameters for the
acetylation of numerous aminoglycosides have been deter-
mined [23]. In addition, the conformation of two amino-
glycosides when bound to the enzyme have been studied
by NMR [24]. The structure of AAC(6′)-Ii establishes that
this enzyme belongs to the GNAT superfamily; however,
the overall appearance of the structure differs significantly
from that of AAC(3)-Ia or yHat1. Examination of these
three members of the GNAT superfamily provides insight
into the structural diversity present within this family.
Furthermore, the structure of AAC(6′)-Ii will provide an
important framework for the development of inhibitory
compounds that could reverse antibiotic resistance.
Results and discussion
The full-length structure of AAC(6′)-Ii (residues 1–182) in
complex with AcCoA was determined by multiwavelength
anomalous diffraction (MAD) using a selenomethionine-
substituted protein. Diffraction data from a single crystal
were collected at the CHESS F2 beamline under cryo-
genic conditions to a resolution of 2.7 Å (see Materials and
methods section). The experimental electron-density map
obtained was of excellent quality and a model for the
enzyme could be readily traced (Figure 1). The structure
has currently been refined to a crystallographic R factor of
18.8% and an R free of 23.4% using data between 40 and
2.7 Å with Fobs > 1σFobs (i.e. 99.7% of all available data)
[25]. The model contains 181 of the possible 182 residues,
one AcCoA molecule and 28 ordered solvent molecules;
the last residue in the sequence is disordered and was not
modeled. The structure of the AAC(6′)-Ii–AcCoA
complex displays good stereochemistry as assessed by the
program PROCHECK [26] (e.g. 99% of nonglycine
residues are placed within the favorable regions of the
Ramachandran plot).
Architecture of the AAC(6′)-Ii enzyme
The AAC(6′)-Ii protein is a single domain structure con-
sisting of α helices and β strands (Figures 2a and b). The
shape of the molecule can be likened to an embellished
letter V, with the AcCoA-binding site positioned in-
between the two arms. Residues 1–103 make up the N-
terminal arm (the right arm in Figure 2a), and residues
104–182 form the C-terminal arm. The core of the N-ter-
minal arm of the molecule consists of a four-stranded
antiparallel β sheet formed by strands β1 to β4 in the order
β1-β2-β3-β4. Around this sheet are positioned three
helices, one on top (α1), one in front (β2) and one behind
the antiparallel β sheet (α3). The C-terminal arm of the
molecule is built around a three-stranded antiparallel
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Figure 1
Experimental electron-density map of the AAC(6′)-Ii–AcCoA complex.
The electron-density map was calculated to 2.8 Å resolution using
MAD phases, generated from four selenium sites that were modified by
the program SOLOMON [34,35]. The map is contoured at 1σ [34,35].
Shown is the region about the β bulge in strand β4 involving Pro75,
which is in the cis conformation.
β sheet, which has the order β5-β7-β6. This C-terminal
β sheet is flanked by two helices, which are located on top
(α4) and behind (α5) the sheet in the orientation shown in
Figure 2a. The joint between the two arms is formed by
the first five N-terminal residues of strand β4 and the first
four residues of strand β5, which are parallel; thus, at the
bottom of the letter V the N- and C-terminal sheets merge
into a mixed parallel/antiparallel β sheet (Figure 2c). The
C-terminal tail of the enzyme (residues 176–182), of which
the last residue has poor to nonexistent electron density
and was thus not included in the current model, is
directed away from the molecule. This tail is for the most
part in an extended conformation and forms no intramole-
cular interactions. However, examination of crystal
packing reveals that the C-terminal residues that could
reliably be modeled (residues 176–181) form extensive
intermolecular interactions. Therefore, it is likely that in
solution the seven C-terminal residues possess no rigid
conformation, but are fully flexible.
The overall fold of the AAC(6′)-Ii molecule, as shown in
Figures 2a and b, reveals an apparent pseudo-twofold
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Figure 2
Schematic representations of the three-
dimensional structure of the AAC(6′)-
Ii–AcCoA complex highlighting different
aspects of the fold. (a) Stereoview Cα trace
of AAC(6′)-Ii–AcCoA in an orientation that
emphasizes the likeness of the fold to an
embellished letter V. (b) Drawing of the
enzyme–AcCoA complex highlighting the
different secondary structure elements:
β strands are shown in yellow and α helices in
blue. The bound AcCoA molecule is shown in
ball-and-stick representation. The complex is
shown in the same orientation as in (a) and
also rotated 90° about the vertical axis. (c) A
detailed view of the region where the N- and
C-terminal arms are joined, focusing on the
β bulge involving cis Pro75. Shown are the
backbone atoms and hydrogen bonds for
β strands β3–β7, plus all atoms of Pro75. The
two orientations differ from each other by a
90° rotation about the vertical axis. (The figure
was generated using BOBSCRIPT [40] and
RASTER3D [41]; secondary structure
elements were assigned using the program
DSSP [42].) 
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symmetry between the N- and C-terminal arms. In fact,
the helix-helix-strand-strand motif in the N-terminal arm
(α1-α2-β2-β3) can be overlaid convincingly with the iden-
tical motif in the C-terminal arm (α4-α5-β6-β7). This
observation suggests that gene duplication might be one
of the events in the evolution of this acetyltransferase
enzyme. However, no sequence similarity, either at the
amino acid level or the nucleotide level, can be discerned
for the structurally homologous regions. Thus, it might be
that the observed internal symmetry of AAC(6′)-Ii is
purely coincidence. An alternative hypothesis is that the
gene duplication event occurred too long ago to be appar-
ent by sequence similarity, and can only be observed
through structural similarity.
An intriguing structural feature of the AAC(6′)-Ii molecule
is the region where the N- and C-terminal arms are joined.
As described above, the first five residues of strand β4
(residues 69–73) and first four residues of β5 (residues
105–108) form a parallel β sheet, but after this point the
two strands diverge (Figure 2c). The structural reason for
this divergence is the presence of a β bulge in strand β4
[27]. Residues His74 and Pro75 of the β4 strand and Gly61
of the β3 strand form a classic narrow β bulge, resulting in
a larger than usual twist in the N-terminal sheet. The β5
strand oriented parallel and adjacent to β4 is unable to
accommodate this twist and therefore diverges. The kink
created in strand β4 by the β bulge is further accentuated
by the fact that Pro75 is in the infrequently observed cis
conformation (Figures 1 and 2c).
Analytical gel-filtration experiments indicate that the
AAC(6′)-Ii enzyme is a dimer in solution [23]. However,
in the crystal form there is only one enzyme molecule in
the asymmetric unit (see Materials and methods section).
This observation most probably implies that the symme-
try operator that relates the two molecules in the dimer
species coincides with a crystallographic symmetry opera-
tor. Unfortunately, identifying the physiological dimer
species in the crystal form is complicated by the high
degree of symmetry present in the particular space group
(I4132), that is, there are six distinct dimers of which four
are candidates for the physiological dimer, as judged by
the extent of dimer interfaces. Thus, a definitive identifi-
cation of the AAC(6′)-Ii dimer species will require the
crystallization of AAC(6′)-Ii in another crystal form, and/or
mutational studies of residues in putative dimer inter-
faces. Examination of the four candidates for the dimer
species reveals that dimer formation is unlikely to be
required for catalytic activity, however, as none of the
possible dimer combinations possess a shared active site.
The AcCoA-binding pocket and substrate-binding site
The AcCoA molecule is wedged between the N- and
C-terminal arms of the AAC(6′)-Ii molecule, forming inter-
actions with both. Figure 3 depicts the various interactions
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Figure 3
Interactions between the AcCoA cofactor and
AAC(6′)-Ii. The AcCoA molecule and residues
forming interactions with it are drawn
schematically, with dashed lines indicating
hydrogen-bond interactions and semicircles
denoting hydrophobic contacts. Hydrogen-
bond distances, as observed in the AAC(6′)-
Ii–AcCoA crystal structure, are given in
Ångstroms.
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observed. Of the nine hydrogen bonds present between
the enzyme and AcCoA, most are formed with the N-ter-
minal arm of AAC(6′)-Ii (residues located on loop β4–α3
and helix α3), and only two are formed with the C-terminal
arm (residues located on loop α4–α5 and helix α5). Fur-
thermore, the majority of these hydrogen bonds are made
with mainchain atoms, and only two sidechains interact
with the AcCoA molecule: the Lys149 sidechain amino
group forms a hydrogen bond/salt bridge with the 3′-phos-
phate of AcCoA and a water molecule mediated hydrogen
bond with the adenine ring; and the Thr89 hydroxyl group
interacts with the α-phosphate group. An additional
sidechain–AcCoA interaction may exist between Tyr147
and the AcCoA sulfur atom (distance of 3.7 Å).
A noteworthy feature of the hydrogen-bond interactions
observed between the cofactor and the enzyme is that the
two peptide groups, which are incorporated into the pan-
tothenic acid and β-mercaptoethylamine moieties, effec-
tively extend the N-terminal β sheet by one additional
strand. This pseudo-β-sheet extension emphasizes the
importance of the β bulge in strand β4, for this structural
feature allows strands β4 and β5 to separate sufficiently so
as to make room for the additional pseudo-strand provided
by the AcCoA molecule.
In addition to hydrogen-bond interactions, the AcCoA
molecule makes extensive van der Waal’s contacts with
the enzyme. Specifically, the pantothenic acid and β-mer-
captoethylamine moieties are surrounded by hydrophobic
residues originating from both the N- and C-terminal arms
(e.g. Thr24, Trp25, Leu76, Val78, Pro143 and Phe146).
Furthermore, the binding pocket for the β-methyl group
of the acyl moiety is lined with hydrophobic residues
(Leu73, Pro75 and Leu109) and is deep enough to accom-
modate slightly larger groups, in agreement with the
observation that propionyl-CoA is also a suitable cofactor
for AAC(6′)-Ii [23].
Although the AAC(6′)-Ii crystal structure presented does
not contain an aminoglycoside substrate molecule, the
position of the AcCoA sulfur atom provides a clear indica-
tion where such a substrate must be bound for acetylation
to occur in the ternary complex. Examination of the mol-
ecular surface of the AAC(6′)-Ii–AcCoA complex reveals
that the sulfur atom of the cofactor is positioned at the
bottom of a cleft created by the N- and C-terminal arms.
Specifically, this cleft is formed by the sidechains of
Trp25, Glu27, Glu28, Asp112 and Leu114 (Figure 4). The
size of this cleft is not large enough to function as a
binding site for the complete aminoglycoside substrate,
and it is most likely that only the 6′-amino group will be
positioned in this cleft so as to undergo acetylation. This
observation is consistent with the broad specificity of the
enzyme [23]. Where the remaining part of the aminoglyco-
side antibiotic will be bound, if it is bound in a specific
manner as suggested by NMR studies [24], is less clear.
Considering that aminoglycosides are invariably positively
charged compounds, the obvious location is the front
entrance to the cleft (Figure 4). The wall of this front
entrance is lined by residues again originating from both
the N- and C-terminal arms of the enzyme. The
sidechains participating in this lining are predominantly
negatively charged (i.e. Glu36, Glu39, Glu72 and Asp168),
thus providing a complementary charged surface to the
substrate. The presence of a negatively charged surface
patch, presumably for promoting the binding of aminogly-
cosides, is also observed in all other aminoglycoside-modi-
fying enzymes of known structure [8,14].
Comparison of AAC(6′)-Ii with other members of the GNAT
superfamily
As mentioned above, part of the fold observed in
AAC(6′)-Ii is seen in two other recently solved protein
structures, yeast histone acetyltransferase Hat1 [16] and the
aminoglycoside acetyltransferase from Serratia marcescens,
also known as AAC(3)-Ia [14]. Thus, AAC(6′)-Ii belongs to
the expansive GNAT superfamily of enzymes. The avail-
ability of crystal structures for three different members of
the GNAT superfamily allows for a thorough analysis of the
GNAT superfamily fold.
Figures 5a and b display the three-dimensional structures
of AAC(3)-Ia, AAC(6′)-Ii and yHat1, and their secondary
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Figure 4
The putative aminoglycoside-binding site of AAC(6′)-Ii. The molecular
surface of the AAC(6′)-Ii–AcCoA complex is colored according to
electrostatic potential. The surface potential ranges from –10 to +10kBT
(red to blue, respectively), as calculated using the program GRASP [43].
To highlight the position of the AcCoA sulfur atom, the molecular surface
is partially transparent so that the AcCoA molecule and the AAC(6′)-Ii
fold can be discerned. The orientation of the AAC(6′)-Ii–AcCoA complex
is identical to that shown in the left panel of Figure 2b.
502 Structure 1999, Vol 7 No 5
Figure 5
Structural comparison of AAC(6′)-Ii, yHat1 and AAC(3)-Ia. (a) Crystal
structures of AAC(3)-Ia, AAC(6′)-Ii and yHat1 shown so as to highlight
the common fold shared among GNAT superfamily members. To assist
in the comparison, structurally similar regions are colored the same (i.e.
purple, orange, green, blue and red), and dissimilar parts of the protein
structures are colored white. (b) Linear representation of AAC(6′)-Ii,
yHat1 and AAC(3)-Ia, highlighting the secondary structure elements
and structurally similar regions. The color-coding used follows that
described in (a). (c) Structure-based sequence alignment of the three
GNAT superfamily members for which crystal structures have been
determined. Residues that are functionally or absolutely conserved only
within the AAC(6′)-Ii, AAC(3)-Ia and yHat1 structures are shown boxed
with black lettering. Residues that are also functionally conserved
within closely related sequences are shown boxed with a darkly
shaded background and white lettering. Residues that are absolutely
conserved within this larger sampling of GNAT superfamily members
are shown boxed with a black background and white lettering. Inserts
are shown as open boxes and the number displayed indicates the
number of residues that are inserted at that location. The location of
secondary structure elements is indicated and the color-coding
scheme used follows that of (a) and (b). Residues that are known to
interact with the cofactor are marked with an asterisk, and residues
putatively implicated in substrate binding are indicated by a plus sign.
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structure elements. Virtually all of the AAC(3)-Ia structure,
the N-terminal arm and part of the C-terminal arm of
AAC(6′)-Ii, and the central core of yHat1 share a similar
folding pattern (Table 1). Specifically, the N-terminal
β sheet β1–β4 and helix α3 plus strand β5 (AAC(6′)-Ii
nomenclature) are structurally well conserved. Interest-
ingly, substantial variation can also be discerned. The
notable differences between AAC(6′)-Ii and the other
GNAT structures concern the presence or location of
homologous helices α1, α2 and α5: helix α1 is partly
unwound in the yHat1 acetyltransferase enzyme; helix α2
is shifted and preceded by an additional helix in AAC(3)-Ia
and absent in yHat1; and helix α5 is completely absent in
AAC(3)-Ia, while it is extended into a much longer helix in
the yeast Hat1 structure (α9, yHat1 nomenclature).
The structural similarities and differences observed
between the three available crystal structures of GNAT
superfamily members is surprisingly not reflected in the
sequence similarity. As shown in Figure 5c, of the 84
residues that are structurally identical in the three acetyl-
transferase structures, only three are chemically identical
(3.6%) and nine are chemically similar (10.7%). Further-
more, if the sequence comparison is extended to include
enzymes that are closely related (i.e. acetyltransferases that
are more than 20% identical to AAC(6′)-Ii, yHat1 or
AAC(3)-Ia, such as AAC(6′)-Ia, human Hat1 histone acetyl-
transferase and AAC(3)-Ig, respectively), the sequence
similarity is even further reduced. Only one residue is con-
sistently present (Leu91) and four are functionally con-
served, Val/Ile57, Gly/Ala58, Leu/Ile73 and Gly/Ala88
(AAC(6′)-Ii numbering). Intriguingly, all of these residues
are hydrophobic, suggesting that they are not required for
catalysis, but instead are essential for cofactor binding
and/or folding.
The virtual absence of conserved residues has implica-
tions for the manner in which the AcCoA cofactor is bound
in GNAT superfamily members. Comparison of the inter-
actions observed between the cofactor (either AcCoA or
CoA) and AAC(6′)-Ii, yHat1 and AAC(3)-Ia, reveals that
the predominant hydrogen-bond interactions are with
mainchain amino and carbonyl groups. In fact, five of the
seven mainchain hydrogen bonds observed in AAC(6′)-Ii
are conserved in both yHat1 and AAC(3)-Ia (Figures 3 and
6). The exceptions are the Glu141 hydrogen bond to the
adenine ring, which is not observed in either yHat1 or
AAC(3)-Ia, and the Thr89 amide interaction with the
α-phosphate group, which is absent in the yHat1 crystal
structure. On the other hand, the sidechain interactions
present in the three GNAT superfamily structures are
highly varied. This diversity is perhaps best illustrated by
the observation that the adenine and ribose rings of the
CoA moiety are in different conformations in the
AAC(6′)-Ii, AAC(3)-Ia and yHat1 enzymes (Figure 6).
One sidechain hydrogen bond consistently observed is the
interaction between the hydroxyl group of residue
Ser/Thr89 (124 in AAC(3)-Ia and 233 in Hat1) and the
AcCoA α-phosphate group. This residue is not function-
ally conserved, however, (e.g. in AAC(6′)-Ia a lysine
residue is located at this position).
Assessment of GNAT superfamily sequence motifs
As discussed above, a comparison of the three available
crystal structures of GNAT superfamily members
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Figure 6
Cofactor conformations in AAC(6′)-Ii, yHat1 and AAC(3)-Ia. The figure
shows the AcCoA conformations observed in AAC(6′)-Ii (red) and
yHat1 (green), and the conformation of the CoA molecule seen in
AAC(3)-Ia (blue). Also indicated are the five conserved hydrogen-bond
interactions present between the cofactor molecules and the
mainchain atoms of the different acetyltransferase enzymes. For clarity,
only the mainchain atoms of AAC(6′)-Ii are shown (in gray), overlayed
with the secondary structure assignment as a transparent object.
Table 1
Comparison between the AAC(6′)-Ii, yHat1 and AAC(3)-Ia
crystal structures.
Compared structures Number of residues* Rms differences (Å)†
AAC(6′)-Ii and yHat1 94 2.44
AAC(6′)-Ii and AAC(3)-Ia 88 1.57
yHat1 and AAC(3)-Ia 89 2.41
*Number of residues that are in structurally similar locations (see
Figure 5). †Root mean square (rms) difference in Cα positions between
structurally similar residues.
reveals a near absence of absolutely conserved residues.
Furthermore, examination of the AcCoA-binding site
indicates that hydrogen-bond interactions with the
cofactor are essentially sidechain independent. These
observations suggest that sequence homology between
GNAT superfamily members may be negligible.
However, a novel multiple-alignment and database
search procedure previously identified four conserved
motifs, designated A to D, in the GNAT superfamily
[21]. Of these motifs, all members possess motif A, and
nearly all possess motifs B and D. Motif C is not always
present, however; for example, the yHat1 enzyme and
AAC(6′)-Ii do not have motif C. Given the structural
similarity and diversity among the three GNAT super-
family members for which crystal structures are avail-
able, an evaluation of the structural basis for these
sequence motifs is now possible.
Motif A physically starts at the N-terminal end of strand
β4 and extends into helix α3 (AAC(6′)-Ii nomenclature).
This motif contains three of the five (functionally) con-
served residues identified — Leu/Ile73, Gly/Ala88 and
Leu91 (AAC(6′)-Ii numbering) — which perhaps explains
why sequence alignment methods were able to identify
this motif. On the basis of mutagenesis studies, motif A
has been implicated in the binding of the AcCoA cofactor
(reviewed in [21]), which is consistent with crystal struc-
ture data. Many of the residues belonging to motif A
either hydrogen bond to the cofactor or participate in
hydrophobic interactions (Figure 3).
It has been proposed that motif B is also involved in
cofactor binding [21]. However, validating this role
proves problematic in that the physical location of this
motif differs dramatically in the three available GNAT
superfamily crystal structures. In AAC(6′)-Ii, motif B
starts after helix α4 and includes helix α5 and strand β6.
On the other hand, in the yHat1 crystal structure this
same motif corresponds structurally to helices α9 and
α10 (yHat1 nomenclature), of which helix α9 is partially
homologous to the smaller helix α5 in AAC(6′)-Ii.
Finally, motif B in AAC(3)-Ia starts after strand β5
and includes strand β6 (AAC(3)-Ia nomenclature). Note
that strand β6 has no equivalence in either AAC(6′)-Ii
or yHat1.
For the three acetyltransferase structures, motif C was
thought to only be present in AAC(3)-Ia. In AAC(3)-Ia
this motif corresponds to helix α1. As described above,
the equivalent helix is also present in AAC(6′)-Ii (helix
α1) and in yHat1, where it is partly unwound (helices α6
to α7). Therefore, the apparent absence of motif C based
on amino acid sequence does not indicate the absence of
the corresponding structural elements of this motif, but
rather that the sequence homology at the amino acid level
is undetectable.
Finally, motif D is present in all three acetyltransferase
crystal structures. This motif starts halfway up strand β2
and terminates at the end of strand β3 (AAC(6′)-Ii nomen-
clature). The observation that not all GNAT superfamily
members possess motif D is difficult to interpret as an
absence of the corresponding structural feature (i.e.
strands β2 to β3), considering the importance of the N-ter-
minal β sheet for the fold of the enzyme. Rather, it may
mean that the connecting loop between the two β strands
has varying lengths, such that sequence similarity is diffi-
cult to detect.
Protein acetylation activity of AAC(6′)-Ii
Several lines of evidence indicated that AAC(6′)-Ii may
have protein acetylation activity. Firstly, steady-state
kinetics analysis yielded specificity constants (kcat/Km) in
the order of 103–104 M–1s–1 for aminoglycoside substrates,
well below the 106–108 M–1s–1 values usually associated
with aminoglycoside-modifying and other antibiotic resis-
tance enzymes [23]. Secondly, for aminoglycoside sub-
strates, the steady-state parameter kcat and not kcat/Km was
positively correlated with the minimal inhibitory concen-
tration of antibiotic, which is not consistent with an
enzyme optimized for antibiotic detoxification [23].
Thirdly, the three-dimensional structure of AAC(6′)-Ii
reveals a large cleft in the active-site region, which in prin-
ciple can accommodate proteins (Figure 4). Finally, the
structure shows similarity to yHat1, as described above
(Figure 5; Table 1). We therefore investigated the protein
acetylation capacity of purified AAC(6′)-Ii.
A survey of potential protein substrates, chosen on the
basis of charge diversity and in-house availability, estab-
lished that AAC(6′)-Ii can acetylate proteins. A mixture of
calf histones enriched in H3 (15 kDa, pI = 11.5) and H4
(11 kDa, pI = 11.4), myelin basic protein (18 kDa,
pI = 11.4), and ribonuclease A (16.5 kDa, pI = 8.6) were
readily acetylated, and hen egg white lysozyme less so
(16.2 kDa, pI = 9.1). In contrast, the aminoglycoside
kinase APH(3′)-IIIa (30.9 kDa, pI = 4.4) and yeast
homoserine dehydrogenase (38.5 kDa, pI = 7.35) were
not substrates (data not shown). Thus, AAC(6′)-Ii is able
to acetylate small basic proteins in a discriminate fashion.
In addition to these potential protein substrates, spermi-
dine and serotonin, which are positively charged sub-
strates for two other members of the GNAT superfamily
(i.e. spermidine N-acetyltransferase and serotonin
N-acetyltransferase), were also tested (data not shown).
Neither of these two compounds could be acetylated by
AAC(6′)-Ii, demonstrating that the enzyme is selective in
its activity, and does not merely acetylate any positively
charged substrate.
We further investigated the acetylation of histones and
poly-L-Lys (molecular mass ~1000 Da) to assess the
nature of the acetyltransfer reaction. Histone acetylation
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was dependent upon substrate concentration (Figure 7a),
consistent with enzymatic acyltransfer, but we did not
achieve saturation due to the prohibitively high substrate
concentrations required (> 1 mM). On the other hand,
poly-L-Lys was a ‘well behaved’ substrate with a Km of
38.5 ± 7.8 µM and kcat of 0.0019 s–1 (Figure 7b). Like
many aminoglycoside substrates, poly-L-Lys demon-
strated substrate inhibition with a Ki of 1.78 mM, indica-
tive of a non-productive binding mode. These results and
the fact that 6′-hydroxyl-aminoglycosides are not sub-
strates, but rather competitive inhibitors of AAC(6′)-Ii
[23], support lysine N- rather than serine O-acetylation.
These findings complement the observed structural
homology between AAC(6′)-Ii and yHat1 with functional
similarity, and strengthen the idea of an evolutionary
relationship between the bacterial aminoglycoside acetyl-
transferases and the eukaryotic GCN5-related histone
acetyltransferases.
Biological implications
Resistance to antibiotics by pathogenic bacteria, such as
vanomycin-resistant enterococci (VRE) and methicillin-
resistant Staphylococcus aureus (MRSA), severely com-
plicates the treatment of microbial infections. One of the
possible avenues to circumvent this complication is to
inhibit the biochemical pathways that are responsible for
generating the resistant phenotypes. The acetyltrans-
ferase AAC(6′)-Ii from the pathogen Enterococcus
faecium is responsible for detoxifying a broad spectrum of
aminoglycoside antibiotics, which are clinically used for
the treatment of nosocomial infections. The crystal struc-
ture of this enzyme in complex with the cofactor acetyl
coenzyme A (AcCoA) presents the necessary frame-
work for pursuing the structure-based design of com-
pounds that could obstruct the resistance mechanism for
aminoglycoside antibiotics.
In addition to the practical implications of the
AAC(6′)-Ii–AcCoA crystal structure for the treatment
of bacterial infections, the fold of this enzyme reveals
that AAC(6′)-Ii belongs to the GNAT superfamily.
Structural studies of the GNAT superfamily have been
nonexistent until very recently, even though this super-
family includes many critical enzymes, most notably the
GCN5 histone acetyltransferase. To date, only three
crystal structures of GNAT superfamily members have
been determined, including the AAC(6′)-Ii structure
presented here. Analysis of these three available struc-
tures reveals that the structurally conserved core, con-
sisting of 84 residues, possesses minimal sequence
homology. In fact, the few residues that are functionally
conserved within this core are consistently hydrophobic,
suggesting that they are not required for catalysis. This
observation implies that the mechanism of acyltransfer
for GNAT superfamily members is unlikely to incorpo-
rate a covalent acyl–enzyme intermediate.
Comparisons of the three acetyltransferase crystal struc-
tures revealed two structurally diverse regions — the
C-terminal region after the fifth β strand and the
polypeptide segment following the first helix — which
straddle the AcCoA-binding site. It is probable that these
two regions have a role in substrate specificity. Specifi-
cally, the segment in-between the first helix and strand
β2 can function as a substrate specificity loop in GNAT
superfamily members.
The structural similarity observed between the bacterial
aminoglycoside acetyltransferase and the eukaryotic
GCN5-related histone acetyltransferases posits an evo-
lutionary linkage between these two classes of enzymes.
This linkage is enforced by the observation that
AAC(6′)-Ii is capable of acetylating small basic proteins
in a discriminate manner, similar to histone acetyltrans-
ferases. However, the specific evolutionary pathway that
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Figure 7
Protein acetylation by AAC(6′)-Ii. (a) The acetylation of histones. An
autoradiogram of acetyltransferase reactions analyzed by sodium
dodecylsulfate polyacrylamide gel electrophoresis shows the extent
of histone acetylation catalyzed by AAC(6′)-Ii with increasing
concentrations of protein substrate. Acetyltransferase reactions are
as described in the Materials and methods section. The reactions
were carried out with varying concentrations of histones: lane 1,
5 µM; lane 2, 10 µM; lane 3, 15 µM; lane 4, 25 µM; lane 5, 50 µM;
lane 6, 100 µM; lane 7, 250 µM; lane 8, 500 µM. The positions of
molecular mass standards are indicated. (b) Steady-state kinetics of
acetylation of poly-L-Lys. Poly-L-Lys acetylation was monitored as
described in the Materials and methods section. Data were fit to the
equation v = VmaxS/(Km + S + S2/Ki), which describes substrate
inhibition in the steady state.
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has resulted in the linkage between bacterial antibiotic
resistance enzymes and eukaryotic enzymes involved in
gene regulation is as yet unknown.
Materials and methods
Protein expression, purification and crystallization
The selenomethionyl derivative of AAC(6′)-Ii was obtained by trans-
forming the E. coli methionine auxotroph B834(DE3)/pLys S with a
pPLaac-1 overexpression plasmid containing the aac(6′)-Ii gene
(GenBank accession code L12710) [23]. Cells were thereafter
grown and the protein purified as described previously for the wild-
type enzyme, with the exception that the growth medium used was
that described by LeMaster and Richards supplemented with
50 mg/l of selenomethionine [23,28]. Mass spectrometry analysis of
purified wild-type and selenomethionyl-derivatized enzymes revealed
that all four methionine residues present were fully substituted
by selenomethionine.
Conditions for crystallization were surveyed by the hanging-drop vapor
diffusion technique using a commercially available sparse matrix
screening kit (Hampton Research, Laguna Hills, CA) [29,30]. Promis-
ing conditions were subsequently refined, resulting in the following pro-
cedure. Reproducible, diffraction quality crystals were obtained by
suspending a 6 µl drop, containing 7–10 mg ml–1 of protein, 2 mM
AcCoA, 5% (w/v) D(+)-sucrose and 0.7 M ammonium sulfate, over a
1 ml reservoir of 2.0 M ammonium sulfate at 22°C. Cube-like crystals
grew to average dimensions of 0.2 × 0.2 × 0.1 mm in about two weeks.
These crystals belong to the body-centered cubic spacegroup I4132,
with unit-cell dimensions of a = b = c = 147.0 Å, and one AAC(6′)-Ii
molecule per asymmetric unit.
X-ray data collection, structure determination and refinement
Diffraction data were collected on the F2 beamline, equipped with a
Quantum 4 ADSC CCD detector, at the Cornell High Energy Synchro-
tron Source in Ithaca, NY. Data at four different wavelengths, corre-
sponding to the energy maxima for the real (λ2) and imaginary (λ3)
components of the anomalous scattering, plus two wavelengths below
(λ1) and above (λ4) the Se absorption edge, were measured at
–170°C, from one crystal. Prior to data collection, this crystal had been
briefly dipped in a 2.5 M ammonium sulfate solution saturated with
D(+)-sucrose. Diffraction images thus obtained were processed to a
resolution of 2.7 Å with the data reduction program MOSFLM [31] and
programs from the CCP4 suite [32]. Positions for three of the possible
four Se sites were subsequently determined with the SOLVE package
[33] and refined using the program SHARP [34]. After density modifi-
cation with SOLOMON [35], the coenzyme A moiety of the AcCoA
molecule and 90% of the chain could be readily traced with the graphi-
cal program O [36]. This model was subjected to refinement using 
X-PLOR [37]. The improved phases thus generated allowed for the
identification of the remaining Se site (Met1), and a new experimental
map was calculated with SHARP/SOLOMON utilizing all four Se sites.
This map was used throughout the refinement process to guide model
building. Refinement of the model was hereafter continued, inter-
spersed with manual interventions, which included completion of the
protein structure and addition of ordered solvent molecules until no sig-
nificant improvement could be obtained [38]. Pertinent statistics for
data collection and phasing are shown in Table 2.
Acetyltransferase assays and steady-state kinetic analysis 
Acetylation of histones, type VIII-S (Sigma) and poly-L-lysine (Sigma,
MW ~1000 Da) by AAC(6′)-Ii was evaluated by a phosphocellulose-
binding assay. Acetyltransferase reaction mixtures containing 25 mM
HEPES pH 7.5, 1 mM EDTA, 0.1 µCi [1-14C]AcCoA, 20 pmoles puri-
fied AAC(6′)-Ii, and varying concentrations of substrate, were incu-
bated at 37°C for 10 min for poly-L-lysine and 15 min for histones.
Reactions were applied to P81 cation exchanger chromatography
paper (Whatman) and the samples washed at 70°C for 4 min followed
by several 3 min rinses at 25°C to remove any reagents not bound to
the phosphocellulose. Radioactivity incorporated into either poly-L-
lysine or histones was counted using a Beckman LS 5801 series scin-
tillation counter and the values baseline corrected. Steady-state kinetic
parameters for poly-L-lysine were determined from initial velocities by
direct fitting to an equation describing substrate inhibition using Grafit
3.0 software [39]. For visualization of histone acetylation by AAC(6’)-Ii,
acetyltransferase reaction mixtures were incubated at 37°C for 15 min
and then separated on a sodium dodecyl sulfate (SDS) polyacrylamide
gel followed by autoradiography.
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Table 2
Summary of X-ray data and MAD phasing statistics.
λ1 (0.9809 Å) λ2 (0.9795 Å) λ3 (0.9792 Å) λ4 (0.9770 Å)
Data collection and processing statistics
Resolution (Å) 2.8 2.7 2.7 2.7
Unique reflections 6085 7726 7725 7637
Redundancy 1.8 6.5 6.5 4.4
Completeness (%)* 89.7 (88.9) 99.9 (100.0) 99.8 (100.0) 99.1 (98.5)
Rsym*† 0.127 (0.332) 0.075 (0.188) 0.072 (0.170) 0.097 (0.263)
<I/σ>* 4.3 (1.4) 8.8 (3.8) 9.3 (4.1) 4.9 (1.5)
Phasing statistics at 2.8 Å resolution
Phasing power (four Se sites)‡
isomorphous centric 0.45 0.32 – 0.71
isomorphous acentric 0.49 0.46 – 0.96
anomalous – 1.37 2.19 1.09
Phasing power (three Se sites)‡
isomorphous centric 0.41 0.26 – 0.65
isomorphous acentric 0.44 0.38 – 0.87
anomalous – 1.31 1.95 1.06
*Numbers given in brackets refer to data for the highest resolution
shell. †Rsym = Σ|I–<I>|/Σ<I>, where I is the observed intensity and <I>
is the average intensity from multiple observations of symmetry-related
reflections. ‡Statistics are provided for the phases derived from the
complete heavy-atom model (four Se sites), and for the phases used to
trace the initial model (three Se sites). All values were calculated with
the SHARP package [34].
Accession numbers
The coordinates for the AAC(6′)-Ii–AcCoA complex have been
deposited with the Protein Data Bank with accession code 1B87.
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